ARTICLE | Company News
Imprimis, Turing Pharmaceuticals sales and marketing update
October 26, 2015 7:00 AM UTC
Imprimis launched a low-cost alternative to toxoplasmosis drug Daraprim pyrimethamine from Turing. Imprimis priced its compounded formulation of pyrimethamine and leucovorin at $99 per 100-count bottle.
In September, media reports said Turing increased the price of Daraprim from $13.50 per pill to $750. Turing is the sole supplier of the antiparasitic drug, which has lost patent exclusivity. ...